



Quality in healthcare has been a topic debated in literature
for some time but it has not yet found a clear definition (Reeves
and Bednar, 1994; Mitchell, 2008; Mosadeghrad, 2014; Tradori,
Brescia and Biancone, 2019; Biancone et al., 2020). Normally
quality in healthcare is defined as quality systems or quality
standards, or even considering mixed models (Donabedian,
1981; Chae et al., 2003; Douglas and Fredendall, 2004; Lillrank
and Liukko, 2004; Kwan et al., 2019). At present the reality is
complex and very often bases these parameters on voluntary
organizational efforts (Bode, 2006; Baker et al., 2007; Legido-
Quigley and Nolte, 2008). The analysis conducted focuses on
quality standards definable as process outcomes (Alkhenizan
and Shaw, 2011).
Among the most debated, we find the standards defined by
the Joint Commission of American origin that evaluates the
health performance of the organization based on minimum stan-
dards aimed at guaranteeing patient safety (McIntyre, Rogers
and Heier, 2001; Morath and Turnbull, 2005). The American
surgeon Ernest A. Codman (Roberts, Coale and Redman, 1987)
founded an hospital, called "End Results Hospital" (Neuhauser,
2002) in 1911, and launched the "American College of Surgeons
Program" in 1913 (1917) to evaluate the application of the care
provided. Given that out of 692 hospitals (with at least 100 beds
each one), only 89 were able to meet the efficiency standards
set by the American College. In 1919, a list of five performance
requirements for hospitals was decided to ensure towards an
acceptable minimum (Roberts, Coale and Redman, 1987). The
percentage of hospitals whose activity was shown to comply
with the required standards went from 13% in 1919 to 50% in
1950.
In 1951, to meet both the high costs of various projects and
the growing complexity of clinical reality, the American College
of Surgeons decided to associate with the American College of
Physician, the American Medical Association and the Canadian
Medical Association in order to found the Joint Commission on
Accreditation of Hospitals (Jost, 1994). This non-profit organi-
zation defined the criterion for evaluating the quality of the
"Optimal Standard" as a maximum level reachable on the basis
of the resources available (rather than an excellent in an ideal
sense) leading to the realization of the Accreditation Manual for
Hospitals (1970) as a primary tool for a systematic hospital a-
ccreditation activity (Affeldt, 1980). Such a voluntary accreditation
modelled today to the accreditation of approximately 80% of
American hospitals by a delegation from the US government
(McGreevey, Nadzam and Corbin, 1997; Lam et al., 2018). The
Joint Commission born in America in 1951 has two nonprofit affili-
ate organizations: The Joint Commission Center for Transforming
Healthcare aims to solve health care's most critical safety and
quality problems and Joint Commission Resources (JCR) offers
educational services, publications, and software to complement
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Abstract
Quality in healthcare is a constantly debated topic and has not found a clear definition to date. If we consider the
possible quality standards related to health services, the Joint Commission identifies the main criteria that health
organizations must respect in order to guarantee patient safety. The Joint Commission International – founded in
1994 by the JC – also accredits organizations in countries other than the USA and Canada to ensure better minimum
quality levels. The study investigates the possibility of obtaining a better outcomes of the health structures accredited
in Italy by the Joint Commission International compared to the other the other health organizations of the Italian
system considering the mortality index as an indicator recognized by the literature as a summary indicator of
outcome. The National Outcome Program (PNE) created by the Italian Ministry of Health allows comparative
effectiveness researches based on relative risk. This study performs the analysis based on the results of the past
three years available and on the volume of activities provided. Given a p-value significance index <0.05, the analysis
highlights the absence of a significant difference between accredited and non-accredited structures. The study
contributes to the literature on health system outcomes and performance and has relevance considering researches
in health tourism and health mobility policies fields.
Keywords: PNE; Joint Commission; medical tourism; index of mortality; healthcare quality standard.
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your accreditation experience. Joint Commission International, a
division of JCR, accredits and certifies international health care
organizations.
Currently, the International Joint Commission – founded by
the Joint Commission – also accredits hospitals in other coun-
tries in order to guarantee the quality of services according to
standard criteria (Smith and Forgione, 2007; Longo et al., 2017).
The American health system has prompted many residents to
direct their choice of care to countries where care is cheaper
and more accessible (Yousefian et al., 2013). To this end,
various health facilities have been accredited, especially in Asia,
with the birth of the phenomenon called medical tourism (York,
2008; Pafford, 2009; Heung, Kucukusta and Song, 2011). The
phenomenon of voluntary accreditation of healthcare facilities,
conducted by the International Joint Commission, affects not
only Asia but also other countries, including Italy (Lemarquand,
1993; Arcari, 2003). The evaluation of the performance of the
structures accredited according to the standards of the
International Joint Commission can increase the definition of
better structures in terms of health care and hospitality.
However, numerous American studies show that accredited
hospitals do not achieve better quality levels in terms of mortality
and patient experience (Lam et al., 2018). Therefore, the
question arises as to whether accreditation is related to higher
quality of performance and patient safety that can be assessed
through the mortality index.
For several years, Italy has launched a National Outcome
Program (PNE) evaluation program coordinated by the Ministry
of Health which, through a process of comparative effectiveness
research, allows performance evaluation taking into account
various factors. Therefore, through the analysis of the relative
risk, this study investigates whether the accredited Italian hos-
pitals are better than the national average, the analysis also
takes into account the statistical significance that the program
makes available. The healthcare facilities considered are all part
of the Italian public national healthcare system as there are no
private structures in the PNE surveys.
To date, no studies are investigating the phenomenon of co-
rrelations between IJC accreditation and hospitals effectiveness
results in Italy. Instead it could be useful, if we consider the new
directives which intend to increase the phenomenon of medical
tourism in Italy while keeping the phenomenon under control.
2. Literature review
2.1. Joint Commission, Joint Commission
International and quality standards
The Joint Commission (www.jcrinc.com) (3-5) is an American
non-profit, non-governmental entity founded in 1951 that has
accredited over 20,000 healthcare organizations in the United
States to date (Roberts, Coale and Redman, 1987). The mission
is to improve health care for citizens, in collaboration with other
stakeholders, evaluating health organizations, and inspiring them
to excel in providing safe and effective treatments of the highest
quality and value (Nadzam, 1991). Today the Joint Commission,
made up of approximately 500 employees and 700 supervisors,
is led by a 28-member Commission, an expression of the
associations of nurses, consumers, doctors, clinical directors,
administrators, producers, trade union organizations, quality ex-
perts, insurers, trainers, etc. The multidisciplinary composition
brings to the Joint Commission the most varied experiences in
the field of assistance and health policy. The structures that are
evaluated and accredited include general, psychiatric, paediatric,
rehabilitation hospitals; welfare networks; home service organi-
zations and support services, home infusion therapy and other
drug treatment services; hospice; programs for subacute di-
seases, dementia and long-term care; mental health and deto-
xification services, services for the disabled, outpatient services;
clinical laboratories.
In 1994, the US Joint Commission founded the Joint Commi-
ssion International (JCI) in response to numerous requests from
hospitals in other countries around the world (Donahuae e
Vanostenberg 2000). To date, JCI has accredited hospitals and
other healthcare institutions in more than 90 countries around
the world. JCI currently has three affiliated agencies in Europe,
Asia, and South America. To obtain and maintain The Joint
Commission's Gold Seal of Approval it is necessary to support
and pass a site visit on all standards, and accreditation is valid
for three years. Besides, JCI works with health care organi-
zations, governments, and sponsors internationally to promote
rigorous standards of care and provide solutions to achieve
optimal results. JCI experts assist organizations in three ways:
accreditation, training, and consultancy services (Robinson,
1995). The development of better standards for patient care and
the evolution of results-oriented processes towards the patient
has earned her the international recognition of leaders in health-
care.
This is why theWorld Health Organization (WHO) joined JCI
to found the first WHO Collaboration Centre for patient safety
solutions (Baretich, 2020). A working group developed the
international standards made up of 16 members from all over
the world, including doctors, nurses, administrators, and policy
experts, subsequently reviewed in over ten countries and then
discussed in six focus groups. The standards relating to "Patient
and family rights" and to "Infrastructure Management and
Security" required two specific panels of experts. After the
second phase in which the verification process was tested in five
countries, the JCI standards were finally approved by the JCI
team and JCI board.
Hospital standards are assessed on three levels every three
years: the Joint Commission Committee for international accre-
ditation proposes variations based on visits and international
literature; the proposals are sent to the referents of the
participating hospitals to express their opinion on the criteria of
relevance, feasibility, and relevance. The Joint Commission
Resources Board of Directors (team of healthcare experts who
oversee define and interpret standards) provides the final opi-
nion on maintaining or modifying current and proposed standards.
The manual is republished every three years after consulting the
accredited organizations. In the various editions, while keeping
the structure firm, the standards have been refined, and the
level of requirements has been raised, leading the organizations
that accredit or renew accreditation to essential efforts in terms
of quality and safety. In this regard it is recalled that since 2009
the International Patient Safety Goals have been introduced
which deal with topics such as safety for the prevention of acci-
dental falls, safety in hand washing, safety in the surgical act,
safety in the use of high-risk drugs, safety in the identification of
the patient and safety in communication between operators, all
considered essential standards for obtaining accreditation and
fundamental for not endangering the patient's life or safety
(Wachter, 2010). The manual contains hundreds of standards
that collectively include thousands of measurable elements. The
standards are organized into chapters that embrace the hospital
organization globally on all processes. The phases that charac-
terize the accreditation process include four phases. The process
lasts for a maximum of 26 months. Phase 1 self-evaluation of
the possession or not of the requisites required (pre-survey
evaluation) (1st month). Phase 2 creation of improvement
groups and production of improvement projects to meet the
requirements (duration from 12th month to 18th). Phase 3 accre-
ditation visit (survey) (duration from 18th month to 24th). Phase
4 accreditation (duration from 20th month to 26th). During the
visit, JCI representatives carry out training and consultancy acti-
vities and provide recommendations to facilitate the achievement
of standards. If the requirements are achieved, the organization
passes the fourth phase and reaches accreditation valid for
three years. The possible levels are identified in: accreditation
status or accreditation rejected.
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2.2. Italian PNE and comparative effectiveness
research
The progress of study design and statistical analysis me-
thodologies and the ever-increasing availability and validity of
information systems and databases in advanced health systems
have highlighted the role of "comparative effectiveness research"
(Garber, 1992; Hernán, 2011; Gargon, Gorst and Williamson,
2019). It is intended as a comparative observational assessment
of health services and interventions. The comparative assess-
ments of hospitals, by structure, by diagnosis, by procedures, by
organizational characteristics, are cases of application of the
methods of comparative effectiveness research (de Lemos and
Nallamothu, 2020). At the international level, the experiences of
comparative assessment among structures have been consoli-
dated for several years.
The Italian National Outcome Program (PNE – Piano Nazio-
nale Esiti) is developed by Italian National Agency for Regional
Health Services (AGENAS) on behalf of the Ministry of Health
and provides a national level of comparative evaluation of the e-
fficacy, safety, efficiency, and quality of the care produced within
the health service. The areas of assessment are, as regards the
production function, the individual hospitals, and, as regards the
protection or commissioning function, the local health compa-
nies. The critical and administrative issues that must have
greater relevance are discussed within the PNE Committee,
made up of representatives of Regions, Autonomous Province,
Ministry of Health and scientific institutions. Design, manage-
ment, the definition of control, data analysis, and management
of the website are carried out by the Epidemiology Department
of the regional health service of the Lazio Region, as the PNE
operations centre of AGENAS.
Italian PNE measures are evaluation tools to support clinical
and organizational auditing programs aimed at improving effec-
tiveness and equity in the National Heath System. PNE does not
produce rankings, evaluations, or report cards. The process
leading to the definition of an outcome indicator begins with a
systematic review of the medical-scientific literature relating to
the treatment or therapeutic, diagnostic course that is intended
to be assessed. The information derived from this first revision
phase allows to define a first version of the protocol to be used
to conduct preliminary analyzes that will allow to verify the
validity of the indicator. The indicators are documented by
protocols with an explicit definition of the outcome in the study,
of the selection criteria of the cases, of the follow-up times, of
the sources of the data and of the factors used for the risk
adjustment. The results of the preliminary analyzes are sub-
jected to the evaluation of representatives of the reference
scientific societies, panels of experts, and further clinicians
discussed within the PNE Committee.
Literature outlines that outcome indicators measure the
outcome of a care process in terms of clinical outcomes (e.g.,
mortality, disease, hospitalizations) (Tu et al., 2003). Their
relationship with the measured phenomenon is influenced by
several determinants that are not directly correlated with the
quality of the care process (risk markers, environmental factors,
socio-economic variables), and that must be considered and
possibly corrected while figuring indicators. The robustness of
the outcome indicators also depends on the time elapsed
between the measurement and the actual delivery of the health
service. Process indicators measure the degree of adherence of
the care process to the reference standards of best evidence-
based clinical practice. For this reason, they are considered
proxies of the outcomes of the assistance and their robustness,
understood as predictive of the clinical outcomes, depends on
the strength of the clinical recommendation and the degree of
evidence on which they were built. In addition, indicators of
activity volumes are calculated for health interventions for which
scientific evidence is available of the association between vo-
lumes of activity and outcomes of care (Halm, Lee and Chassin,
2002). Finally, the quality of territorial assistance is assessed by
measuring the so-called "ambulatory care sensitive conditions"
(ACSC), which can be defined as situations in which quality
territorial assistance allows avoiding the use of avoidable hospi-
talizations or early intervention allows preventing complications
or more pathologies serious (Ansari, Laditka and Laditka, 2006).
2.3. Index of mortality
In literature, the most used outcome of healthcare service in
studies is the rate of intra-hospital mortality within 30 days of
discharge (Thomas, Longford and Rolph, 1994; Leyland and
Boddy, 1995; Goldstein and Spiegelhalter, 1996; Marshall and
Spiegelhalter, 1999, 2001). The mortality rate is the ratio be-
tween the number of deaths in a community of people over a
period of time and the amount of the average population over
the same period (Gryfe, Amies and Ashley, 1977). The mortality
rate measures the frequency of deaths of a population over a
period of time and is normally referred to a calendar year. This
data is used to verify the negative state of development of a
population. The mortality rate for a given year is equal to a
houndred times the ratio between the number of deaths in that
year and the average population. Although some authors have
stated that the indicator alone is not enough to define the out-
come of treatments (Epstein, 1998; Marshall and Spiegelhalter,
2001), it is also true that it is the easiest to calculate and monitor.
Clinical or clinical outcome indicators can be used to solve the
problem epidemiological, specific for each pathology, built accor-
ding to criteria derived from the scientific literature, collected ad
hoc, or from medical records or documentation directly related
to the treatment. This is already happening in some countries
due to the mortality rate, which is systematically collected by the
hospital and geographical areas, in some cases taking into
account the individual characteristics of the patients undergoing
edited thanks to the use of the same or similar methodologies.
In Italy the National Outcome Program (PNE) already considers
this information gathering approach. According to Birkmeyer
(Birkmeyer et al., 2002; Ghaferi, Birkmeyer and Dimick, 2011)
the analyzes of those kind of dataset overall show an inverse
relationship between the volume of activity and mortality,
confirming that this association has to do with quality. The study
focused – in the Italian context – on the possible relationship
between the volume of activity and quality would derive from the
fact that the volume can be considered a good proxy of the
experience of the providers of the choice of the providers of the
citizens. The PNE considers only the statistically significant
thresholds for assessing the mortality rate for each health ser-
vice observed. If the number of cases is not sufficient for the
expected mortality rate, the PNE does not present the result.
3. Method
The measure used to determine whether the structure is sta-
tistically better than the national average or the benchmarking
average is the Relative Risk (RR) (Dyer and Sarin, 1982). The
RR is calculated as the ratio between two rates / proportions and
expresses the excess (or defect) of risk of the group placed in
the numerator compared to the group placed in the denominator
(Barlow and Prentice, 1988). For example, if for the healthcare
organization of residence A the mortality RR compared to Health
organization B (reference area) is equal to 2, it can be con-
cluded that the residents in Health Organization A have a risk of
death twice higher than that of residents of Health Organization
B. Vice versa, if for the Health Organization of residence C the
mortality RR is 0.25, the residents of this Health Organization
have a risk of death four times smaller than that observed in the
reference Health Organization.
For some indicators the measure the association used is the
Hazard Ratio (HR), interpretable as an instant RR. The relative
risk measure adopted in this case takes into account the morta-
lity rate identified as a useful indicator to define the practical
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effectiveness of the treatments, the parameter takes into
account comorbidity and specific epidemiological criteria for
each pathology (Miettinen, 1970). The data is also related to the
volume of activity provided (Landis, 2004). The p-value that the
PNE identifies for each mortality rate allows to determine the
significance of the same with respect to the national sample
(Parvizi, Ereth and Lewallen, 2004; Reid et al., 2009; Devereaux
et al., 2012). The value of p represents the probability that the
observed Relative Risk differs from one (null hypothesis) only as
a result of the case. A p-value close to unity indicates, for
example, that a mortality RR is no different from 1; in other
words, the mortality rates in the two groups compared are not,
from a statistical point of view, significantly different. On the
other hand, a low p-value indicates that the difference observed
between the two groups cannot be attributed solely to the effect
of chance. P-values less than or equal to 0.05 indicate that the
mortality rates in the two groups are, from a statistical point of
view, significantly different (Afifi and Elashoff, 1967; Marill, 2004;
Bailar and Hoaglin, 2012).
3.1. The sample
The analyzed sample was obtained manually from the Joint
Commission website. The structures were accredited before
2016.
The sample consisted primarily of 23 healthcare facilities
located on the Italian territory. However, 9 structures were not
considered as they are not present in the PNE, as they are
rehabilitative or diagnostic and do not involve a collection of
mortality rates (CDI Centro Diagnostico Italiano S.p.a. – Milan,
Ceinge Biotecnologie Avanzate scarl – Napoli, Fondazione
Centri di Riabilitazione Padre Pio ONLUS San Giovanni
Rotondo – Milano, Istituto Mediterraneo per i Trapianti e le
Terapie ad Alta Specializzazione – Palermo, S.D.N. S.p.A. –
Napoli, Santa Chiara Hospital – Trento, UPMC San Pietro FBF
– Advanced Radiotherapy Center – Roma, A.p.s.p. Residenza –
Valle dei Laghi Cavedine, Casa di Cura Villa San Benedetto –
Menni Albese con Cassano. A structure is located on the Vatican
territory; therefore, it is not considered in the Italian databases
(Ospedale Pediatrico Bambino Gesù – Roma). There were also
5 structures that, by volume of cases treated, did not gather
representative mortality data and therefore, were not considered
(Centro Chirurgico Toscano Srl – Arezzo; IRCCS Centro San
Giovanni di Dio Fatebenefratelli – Brescia, Istituto di Medicina
Fisica e Riabilitazione "Gervasutta" – Udine, Giannina Gaslini
Children's Hospital – Genova; Presidio Ospedaliero Ospedale
dei Bambini – Brescia).
Therefore, the study was able to consider the results of the
specialist activities of 8 facilities. These are located as follows: 5
structures in northern Italy, 2 in the south Italy and 1 in the
central Italy. The activities which have resulted mappable by
structure fall in a range from one to eighteen. These specia-
lizations have resulted in having gathered measures of mortality
rate detectable thirty days after the different intervention.
4. Result
Accredited Joint Commission Structures present on average
a relative risk better than other national health structures, also
considering the volume of services performed (see table 1).
In some years the structures do not reach the minimum
thresholds of performance volumes in order to be able to con-
sider the data reliable. Nevertheless, the p-value almost always
shows a lack of significance of the result, however not confirmed
in the three years considered. This result excludes the possibility
of affirming a continuity of the significance of the rate concerning
the national average in consecutive terms.
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1) COT Cure Ortopediche Traumatologiche S.p.A. Messina (Southern Italy)
Chronic renal failure: mortality 30 days after
hospitalization 0.16 0.068 0 0.26 0.057 0 0.52 0.146 0
European Institute of Oncology (Istituto Europeo di Oncologia) Milano (Northern Italy)
TM kidney surgery: 30-day mortality 0.37 0.322 0 0.41 0.377 0 0.41 0.376 0
TM stomach surgery: 30-day mortality 0.34 0.134 0 0.30 0.188 0 0.37 0.156 0
TM colon surgery: 30-day mortality 0.59 0.369 0 - - - - - -
Rectal TM surgery: 30-day mortality 0.80 0.821 0 - - - - - -
Surgery for TM lung: 30-day mortality 0.65 0.262 0 - - - 0.73 0.418 0
Surgery for TM prostate: 30-day readmissions 1.26 0.301 0 - - - 0.99 0.962 0
Fondazione Poliambulanza Brescia Northern Italy)
Acute myocardial infarction: 30-day mortality 0.83 0.415 0 0.57 0.053 0 0.74 0.277 0
TM kidney surgery: 30-day mortality 0.59 0.612 0 - - - - - -
Surgery for liver TM: 30-day mortality 0.95 0.946 0 - - - - - -
Brain T surgery: mortality 30 days after craniotomy 1.11 0.807 0 0.68 0.504 0 0.43 0.234 0
Chronic renal failure: mortality 30 days after
hospitalization 0.76 0.390 0 0.50 0.082 0 0.80 0.263 0
Isolated Aortocoronary bypass: 30-day mortality 0.34 0.128 0 0.25 0.169 0 0.66 0.558 0
Congestive heart failure: 30-day mortality 1.16 0.318 0 1.20 0.212 0 1.08 0.569 0
Repair of unbroken abdominal aortic aneurysm:
30-day mortality 0.32 0.251 0 0.59 0.466 0 0.66 0.558 0
Non-varicose hemorrhage of the upper intestinal
tract: 30-day mortality 0.58 0.226 0 0.79 0.568 0 0.97 0.943 0
Acute myocardial infarction without PTCA: 30-day
mortality 0.91 0.724 0 0.60 0.208 0 0.93 0.839 0
Femoral neck fracture: 30-day mortality 0.69 0.326 0 0.91 0.791 0 0.64 0.281 0
Ischemic stroke: 30-day mortality 0.94 0.735 0 0.56 0.021 1 0.47 0.005 1
COPD exacerbated: 30-day mortality 1.20 0.353 0 0.86 0.483 0 1.06 0.751 0
TM stomach surgery: 30-day mortality 0.45 0.173 0 0.35 0.136 0
TM colon surgery: 30-day mortality 0.66 0.422 0 0.78 0.595 0 0.54 0.223 0
Rectal TM surgery: 30-day mortality 1 0.997 0 - -
Acute Myocardial Infarction with execution
of PTCA within 2 days: mortality at 30 days 0.92 0.826 0 0.72 0.421 0 0.74 0.277 0
Surgery for TM lung: 30-day mortality 1.79 0.420 0 0.88 0.898 0 1.10 0.923 0
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2) Humanitas Gavazzeni Bergamo (Northern Italy)
Acute myocardial infarction: 30-day mortality 0.63 0.232 0 0.86 0.660 0 0.58 0.192 0
Surgery for liver TM: 30-day mortality 0.60 0.611 0 - -
Chronic renal failure: mortality 30 days after
hospitalization 0.48 0.048 1 0.88 0.662 0 0.36 0.004 1
Isolated Aortocoronary bypass: 30-day mortality 0.16 0.064 0 - - 0.45 0.177 0
Valvuloplasty or replacement of heart valves:
30-day mortality 0.68 0.350 0 0.52 0.150 0 0.38 0.053 0
Congestive heart failure: 30-day mortality 0.52 0.108 0 0.19 0.020 1 0.55 0.139 0
Repair of unbroken abdominal aortic aneurysm:
30-day mortality 0.53 0.522 0 1.q2 0.869 0 1.98 0.24 0
Femoral neck fracture: 30-day mortality 1.98 0.018 1 1.09 0.833 0 0.58 0.281 0
TM stomach surgery: 30-day mortality 1 0.994 0 1.20 0.720 0 0.62 0.508 0
TM colon surgery: 30-day mortality 0.52 0.220 0 0.65 0.421 0 0.23 0.146 0
Surgery for TM lung: 30-day mortality 1.61 0.294 0 0.88 0.822 0 - - -
3) Humanitas Istituto Clinico Catanese Catania (Southern Italy)
Surgery for TM lung: 30-day mortality 0.70 0.727 0 - - - - - -
4) IRCCS Istituto Clinico Humanitas Milano (Northern Italy)
Acute myocardial infarction: 30-day mortality 0.35 0.012 1 0.64 0.159 0 0.57 0.136 0
Acute Myocardial Infarction: 30-day mortality
(main diagnosis) 0.35 0.020 1 - - 0.33 0.006 1
TM kidney surgery: 30-day mortality 0.64 0.532 0 0.80 0.548 0 0.32 0.254 0
Surgery for TM pancreas: 30-day mortality 0.21 0.118 0 - - - - - -
Surgery for liver TM: 30-day mortality 0.23 0.140 0 0.85 0.741 0 0.60 0.383 0
Brain T surgery: mortality 30 days after craniotomy 0.63 0.195 0 0.42 0.034 1 0.47 0.032 1
Chronic renal failure: mortality 30 days after
hospitalization 0.62 0.032 1 0.37 0.000 1 0.32 0.254 0
Valvuloplasty or replacement of heart valves:
30-day mortality 0.71 0.363 0 0.47 0.131 0 0.47 0.068 0
Congestive heart failure: 30-day mortality 0.27 0.001 1 0.26 0.000 1 0.33 0.006 1
Repair of unbroken abdominal aortic aneurysm:
30-day mortality 0.47 0.453 0 0.18 0.089 0 - - -
Non-varicose hemorrhage of the upper intestinal
tract: 30-day mortality 0.84 0.725 0 0.59 0.365 0 0.42 0.225 0
Femoral neck fracture: 30-day mortality 0.14 0.050 0 0.18 0.089 0 0.69 0.523 0
Ischemic stroke: 30-day mortality 0.81 0.413 0 0.44 0.016 1 0.52 0.027 1
COPD exacerbated: 30-day mortality 0.40 0.042 1 0.37 0.046 1
TM stomach surgery: 30-day mortality 0.58 0.287 0 0.14 0.051 0 0.49 0.230 0
Acute Myocardial Infarction with execution
of PTCA within 2 days: mortality at 30 days 0.38 0.177 0 1.25 0.000 1 0.57 0.136 0
Surgery for TM lung: 30-day mortality 1.38 0.341 0 0.98 0.953 0 0.86 0.722 0
5) Istituto Clinico Mater Domini - Casa Di Cura Privata Spa Castellanza (Northern Italy)
Acute myocardial infarction: 30-day mortality 0.72 0.463 0 0.57 0.274 0 0.79 0.514 0
TM kidney surgery: 30-day mortality 1.19 0.862 0 - - - - - -
Congestive heart failure: 30-day mortality 1.10 0.683 0 1.22 0.413 0 1.39 0.541 0
Femoral neck fracture: 30-day mortality 0.61 0.486 0 0.22 0.136 0 0.50 0.327 0
COPD exacerbated: 30-day mortality 0.92 0.834 0 1.47 0.178 0 1.51 0.130 0
TM colon surgery: 30-day mortality 0.32 0.263 0 0.53 0.382 0 0.32 0.267 0
Acute Myocardial Infarction with execution
of PTCA within 2 days: mortality at 30 days 0.36 0.317 0 - - - 1.14 0.797 0
6) Policlinico Universitario Campus Bio-Medico di Roma (Center of Italy)
TM kidney surgery: 30-day mortality 1.46 0.605 0 1.61 0.505 0 1.83 0.399 0
Surgery for TM pancreas: 30-day mortality 2.29 0.090 0 1.38 0.646 0 0.93 0.918 0
Surgery for liver TM: 30-day mortality 0.70 0.726 0 1.50 0.573 0
Isolated Aortocoronary bypass: 30-day mortality 1.11 0.755 0 1.12 0.740 0 1.90 0.036 1
Valvuloplasty or replacement of heart valves: 30-
day mortality 0.51 0.128 0 0.83 0.609 0 1.14 0.720 0
Congestive heart failure: 30-day mortality 0.72 0.389 0 0.32 0.050 0 0.37 0.003 1
Repair of unbroken abdominal aortic aneurysm:
30-day mortality 0.77 0.790 0 1.51 0.477 0 0.91 0.894 0
TM stomach surgery: 30-day mortality 1.68 0.238 0 1.13 0.836 0 1.05 0.932 0
TM colon surgery: 30-day mortality 0.38 0.189 0 0.45 0.279 0 0.21 0.127 0
Rectal TM surgery: 30-day mortality 1.69 0.472 0 1.44 0.615 0 0.82 0.844 0
Surgery for TM lung: 30-day mortality 2.45 0.074 0 2.12 0.098 0 - - -




The PNE develops in the Italian Health Service the evalu-
ation of the outcomes of health surgical procedures. These can
be defined as the estimate, with observational (non-experi-
mental) study designs, of results of health treatments. The main
objectives of PNE concern the comparative evaluation between
providers. It is indeed useful in identifying weaknesses, con-
sequences on the accreditation conditions, differences due to
geographical location and consequently and finally fairness in
health cares access.
The analysis of the performance of healthcare activities on
the basis of the thirty-day mortality index, allows to evaluate the
structure position, the relative risk and the relative p-value of
significance with respect to the national average. This was done
taking into account the volume of performance and other de-
termining factors of the index itself.
The analysis conducted over three years shows the lack of a
sufficient degree of significance despite the level of performance
being almost always better than the national average.
Therefore, it is not possible to claim that accredited health
facilities by the Joint Commission International (JCI) are better
than the others belonging to the Italian health system. Non-
accredited healthcare structures figure out performance similar
to the one of JCI accredited facilities. There is no significant
difference.
The results clearly show the existence of an inverse
correlation between the structural features of the national health
systems where JCI accredited facilities are located and the
relevance of certification as a tool for differentiation. The stron-
ger the first, the lower can be expected to be the second. Italy is
among the top countries in terms of care performance. Minimum
standards (or LEA – Livelli Essenziali di Assistenza) are defined,
compulsory and marked out in each district. The Italian health
system requires LEA to be implemented by every single facility
to guarantee patient safety (France, Taroni and Donatini, 2005).
At the same time they represent services that the Italian
National Health Service (SSN) provides to all citizens, free of
any direct charge or upon payment of a flat fee and financed
with the public resources collected through the general taxation
(Turati, 2013). The Italian Health Service in fact bases its fun-
damental principles (Law 833 of 1978) on universality, equal
rights and fairness (Guillén, 2002). Since 1978, in Italy, there
has been a transition from a mutual system or Bismarck model
to a Beveridge model, which in any case factually affects the
approach to access to care and accreditation of the health
system based on minimum principles and standards (Cichon
and Normand, 1994; Simonet, 2009). The American model in-
stead needs a certification for the determination of minimum
levels to guarantee the security of access to adequate care as it
is based on a neoliberals free-market model (Saad-Filho, 2019).
Universality means an extension of health services to the
whole population in compliance with art. 32 of the Italian
Constitution that literally says: “The Republic protects health as
a fundamental right of the individual and an interest of the
community, and guarantees free care to the poor”. Health has
considered to be not only as an individual good but above all as
a community resource (Ferrera, 1995). Starting from 1978, the
NHS applies this principle through the promotion, maintenance,
and recovery of the physical and mental health of the entire
population with a widespread organization throughout the
country whose services are provided by local health companies,
hospital companies, and private affiliated structures with the
SSN. All of this facility together aim at uniformly guarantee the
Essential Levels of Assistance (LEA) to the entire population.
Equal rights mean that citizens must be able to access the
NHS services without any individual, social and economic
distinction. Citizens, who do not belong to exempt categories,
are required to pay a flat fee – called “ticket” – that varies for
each service provided by the LEA. Finally, equal rights mean
guarantee of equal health care access in relation to equal health
needs. This main basic principle aims to overcome citizens'
inequalities allowing to everybody access to health services.
To recognize equal rights to citizens it is necessary to gua-
rantee fairness that means quality, efficiency, appropriateness
and transparency of the service. A fair communication on the
Health Service itself is necessary for the citizens. It has to be
adequate for his level of education and understanding (informed
consent, taking charge) and has to be prepared and provided by
doctors, nurses and health workers.
The principles discussed inform the Italian culture and have
over time pushed the Italian Healthcare System to guarantee
minimum quality standards. The impact on our research is rele-
vant as we saw that it led to not having statistically significant
differences between accredited Joint Commission International
structures and national averages.
It sounds interesting to point out that the JCI accreditation
process did not reveal any real improvement even in the
American countries where the system is more widespread and
constrains the public funding of the Medicare programs (Griffith,
Knutzen and Alexander, 2002; Lam et al., 2018).
Therefore, the JCI system seems to find optimal application
in countries where no structured health system and rigid controls
based on standards aimed at patient health have not been
implemented yet. An example is the Asian countries where,
although medical tourism is widespread, without accreditation, it
would not be possible to pinpoint high level facilities and con-
sequently to guarantee patient safety standards comparable to
the levels of western countries (Gupta, Verhoeven and Tiongson,
2003).
6. Conclusion
The study proves that there are no differences in per-
formance between structures accredited according to standards
by the Joint Commission International and Italian structures.
It should be noted that in Italy the guarantee of the patients
is guaranteed in any case by the minimum levels of care (LEA)
(Brescia et al., 2017; Campra et al., 2019). The national out-
comes program based on comparative effectiveness research,
although there are no differences between accredited and non-
accredited structures, is nonetheless supportive for carrying out
an evaluation of the performance trend compared to the national
average. It allows indeed a push towards continuous improve-
ment and redefinition of standards specific for health services.
If health services are guaranteed throughout Italy, albeit with
regional differences, then it is possible to affirm that medical
tourism and hospitality can be guaranteed regardless of accredi-
tation according to standards defined by the Joint Commission.
Future analyzes should however verify the same assump-
tions in similar European health systems. It will be necessary to
consider the different health systems characteristics and to
group them into three main categories – public, private or mixed
– considering the country main settings.
The analysis conducted can be helpful for American po-
licymakers, managers, and insurance companies who should
guide their choices rather than on standards accredited by the
Joint Commission International from the evaluation of individual
national culture and settings.
Accreditation seems not to be necessarily synonymous of
higher quality. It requires anyway time and higher costs so that
not all structures get involved in it. This takes to a kind of
adverse selection sometimes excluding good structures from
the medical tourism facilities carnet (Greenfield and Braithwaite,
2009; Mumford et al., 2013).
The study can also provide some first indications that can be
usefully replicated in other European countries regarding on one
hand the expected facilities quality in different European context
and on the other tourism and healthcare mobility in Europe. The
last research field as been explicitly mentioned in Directive
2011/24/EU entitled "Patients' rights in cross-border healthcare".
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Finally, despite mortality index, qualitative perception data
were not available for the Italian context. The provision and
disclosure of information divided by each facility and useful to
carry out the same tests and comparisons already implemented
in America and in other countries could enable to improve the
analysis. For this reason, it is suggested to investigate further in
the future, if and when those data-set will be accessible, the
phenomenon of quality assessment in health systems in the
Italian context.
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